1,291 results on '"Guo, Hongqian"'
Search Results
152. Supplemental Figure 1 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
153. Supplementary Data from Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness
154. Figure S1 from Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study
155. Data from Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness
156. Supplementary Data from Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study
157. Supplemental Table 1-3 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
158. Supplemental Figure 2 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03
159. Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance
160. The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
161. Indications, strategies, and development on prostate targeted biopsy: Report of the Panjiayuan Consensus Conference 2022
162. Is there an impact of transperineal versus transrectal magnetic resonance imaging–targeted biopsy on the risk of ıpgrading in final pathology in prostate cancer patients undergoing radical prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group multi-institutional study
163. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN
164. Cancer Cell-Selective Membrane Receptor Clustering Driven by VEGF Secretion for In Vivo Therapy
165. p53 mutation and deletion contribute to tumor immune evasion
166. Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
167. Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
168. Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis
169. A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recovery
170. Tumor-Intrinsic RGS1 Regulates Checkpoint Blockade Response via ATF3-IFNGR1 Axis
171. Radio Frequency Ablation versus Partial Nephrectomy for Clinical T1b Renal Cell Carcinoma: Long-Term Clinical and Oncologic Outcomes
172. Improved Split Renal Function after Percutaneous Nephrostomy in Young Adults with Severe Hydronephrosis Due to Ureteropelvic Junction Obstruction
173. Small ankyrin 1 ( sANK1 ) promotes docetaxel resistance in castration‐resistant prostate cancer cells by enhancing oxidative phosphorylation
174. NIR‐II Light Powered Asymmetric Hydrogel Nanomotors for Enhanced Immunochemotherapy
175. Development of a Prediction Model for Positive Surgical Margin in Robot-Assisted Laparoscopic Radical Prostatectomy
176. Re: Bernadett Szabados, Mark Kockx, Zoe June Assaf, et al. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder. Eur Urol 2022;82:212–22
177. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis
178. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China
179. Modified laparoscopic simple enucleation with single-layer suture technique versus standard laparoscopic partial nephrectomy for treating localized renal cell carcinoma
180. Reactive Oxygen Species- and Cell-Free DNA-Scavenging Mn3O4 Nanozymes for Acute Kidney Injury Therapy
181. Urinary and Pelvic Solitary Fibrous Tumors: A Study on 22 Patients
182. Effect of extensive artery isolation during robotic-assisted partial nephrectomy on blood pressure of patients with poorly controlled hypertension: a preliminary study
183. Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
184. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study
185. Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
186. TLR7/8-agonist loaded M1 Macrophagederived nanovesicles promote the polarization of macrophages to enhance bladder cancer immunotherapy
187. Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
188. Multicentric experience in Retzius-sparing robot-assisted radical prostatectomy performed by expert surgeons for high-risk prostate cancer
189. Steroid Receptor Coactivator-3 Regulates Glucose Metabolism in Bladder Cancer Cells through Coactivation of Hypoxia Inducible Factor 1α
190. In Situ Floating Hydrogel for Intravesical Delivery of Adriamycin Without Blocking Urinary Tract
191. Evaluation of Quality of Life in Urban Life Circles from a Composite Perspective of Subjective Needs and the Supply of Public Amenities: A Case Study of Changbai Island, Shenyang.
192. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
193. Perioperative outcomes of zero ischemia radiofrequency ablation-assisted tumor enucleation for renal cell carcinoma: results of 182 patients
194. Thermo-sensitive hydrogel for preventing bowel injury in percutaneous renal radiofrequency ablation
195. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy
196. Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients
197. Commentary: High-metastatic melanoma cells promote the metastatic capability of low-metastatic melanoma cells via exosomal transfer of miR-411-5p
198. Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p
199. Identification of Urban Functional Areas and Governance Measures Based on Point of Interest Data: A Case Study of the Shenyang Railway Station Area in Shenyang City
200. Characteristics of peritumoral pseudocapsule in small renal cell carcinoma and its influencing factors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.